Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment
Crossref DOI link: https://doi.org/10.1007/s00277-014-2231-9
Published Online: 2014-10-12
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Breccia, Massimo
Molica, Matteo
Zacheo, Irene
Serrao, Alessandra
Alimena, Giuliana
Text and Data Mining valid from 2014-10-12